You just read:

FDA Allows Ablative Solutions to Initiate its Phase 2 TARGET-BP I Trial of Combination Drug/Device Therapy for Hypertension under its IND

News provided by

Ablative Solutions, Inc.

Sep 13, 2016, 03:00 ET